key: cord-0756221-fxz7bhe1 authors: Cook, T. M.; Camporota, L. title: Critical care outcomes from COVID‐19: patients, interventions, healthcare systems and the need for core datasets date: 2021-07-27 journal: Anaesthesia DOI: 10.1111/anae.15545 sha: 1fe5d4cfb032b2d872890e8c5ae0859a306a00f2 doc_id: 756221 cord_uid: fxz7bhe1 nan admitted to ICU [1] . First, it is worth emphasising that only a minority of patients who have died in the pandemic have done so in ICU: 9% of those in the UK, with a third of deaths occurring outside hospital and six in seven hospital deaths occurring on the wards [2] . The average age of patients admitted to ICU in the UK is 10 years lower than for all hospitalised patients and more than 20 years younger than patients who have died from COVID-19: 61 vs. 73 vs. 83 y [3] [4] [5] . Despite only a minority of patients hospitalised with COVID-19 being admitted to ICU, there has been an enormous focus on critical care during the pandemic and this is appropriate. Early in the pandemic, the high mortality of patients with COVID-19 admitted to ICU was noted, and in China and North America mortalities of >60% were reported, including >90% in those receiving mechanical ventilation [6, 7] . In the first 6 months of the pandemic, global mortality in ICU fell to approximately 35% [8] . There are several potential explanations: first, variability in presentations, type of respiratory support received and specific treatment strategies (a common factor in ICU but amplified during the COVID-19 pandemic); second, an issue with the 'denominator' of the mortality fraction as many early observational studies reported ICU mortality when most patients were still receiving ICU treatment meaning their outcomes were unknown [8, 9] ; third, the role of underlying comorbidities and perceived disease reversibility; and fourth, the incremental understanding of the pathophysiology of COVID-19. Undoubtedly, improved learning about the disease allied with improved management and therapeutics has enabled ICUs to save many lives that a few months earlier would have been lost. Importantly, this has been achieved by collaboration and experience sharing within and between countries [10, 11] and by rapidly executed and disseminated high quality research [12, 13] . What then does the work of Taylor et al. tell us? They have undertaken a meta-analysis of published studies to explore the association between admitted patients' characteristics and ICU outcome. The factors they report to be associated with mortality are generally expected and in line with those in large primary care studies examining allcause mortality from COVID-19 [14, 15] . Essentially, an older patient with more comorbidities, greater disease severity (most markedly lung injury and renal impairment), indices of inflammation and organ dysfunction is more likely to die in ICUregardless of sex or BMI. In terms of methodology, the analysis is constrained by the data available, and these are heterogeneous and fragmentary. There are numerous sources of heterogeneity. First, there is inevitably variation in what is meant by intensive care: an ICU in Yemen or Iran or some parts of Africa [16] [17] [18] is unlikely to be the same, in terms of staffing, infrastructure and facilities, as an ICU in Wuhan or many European, Australasian or North American countries. Second, it is likely that the underlying characteristics of patients admitted to different ICUs will differ. Those in a lower income country are more likely to be younger and fitter, though perhaps with chronic disease from endemic non-COVID-19 infection; and those in higher income countries older and more likely to have the chronic diseases associated with surfeit such as obesity, diabetes, hypertension and ischaemic heart disease. Also, admission to ICU may not be solely an expression of organ dysfunction or disease severity but may depend on other factors including local resources, biases and timing of presentation during the pandemics (i.e. the chance of being admitted to ICU may differ at the peak of a pandemic surge compared with one of the tails). All these factors affect patient selection and crucially baseline characteristics of the patients admitted to ICUand their association with outcome. Third, in locations with differing ICU 'capabilities' (e.g. number of ICU beds per capita, staff or treatments available), the criteria for ICU admission (or non-admission) are likely to vary, as will the ability to provide critical care support for the period of several weeks or months, which is often required to achieve survival in COVID-19 induced severe respiratory or multiorgan failure. This will mean that disease severity on admission, treatments offered, and their duration or withdrawal will have an unpredictable impact on outcome. Fourth, it is likely that surges (which have occurred at different times in different countries) have altered provision of ICU and while in some settings it is self-evident that this has altered ICU admission criteria, capability [19, 20] and therefore outcomes, this effect is more subtle in other counties [21] . Fifth, and intriguingly, it is not clear that the same disease has been treated either over time or by location: it is quite possible that different variants lead to subtly different disease patterns that may alter presentation and mortality and while this remains a matter of debate it is quite plausible for this to impact differentially on ICU survival. Sixth, the data collected and reported between studies differ, but perhaps even more importantly there is lack of consistency in definitions within datasets, for example definitions of comorbidities, hypoxia, renal failure, respiratory, cardiovascular or neurological support and ICU itself. The fragmented nature of data available means several unmeasured factors are likely to impact on outcome. These may be external (e.g. national wealth; critical care provision per capita; level of social deprivation; access to primary care); pandemic-related (e.g. degree of systemic stress in the healthcare system); or patient-related (comorbidities; frailty; natural history and treatment received). While age, comorbidities or smoking status have been reported to influence ICU outcome, other variables require qualification. [14, 15] and large-scale population data. Of note, the ICNARC data documents a fall in mortality in the Spring of 2020, [21] which then rose again in late 2020 and early 2021, coinciding with the period when ICUs again became overburdened in the peak of the second wave [27] . At the peak of the first wave, the baseline characteristics of patients admitted to UK ICUs altered, with a reduction in average age and a change in disease characteristics, perhaps suggesting that care could not be provided for all patients [21] . The ICNARC dataset provides a model for how data should be collected, but even this is limited as the dataset captures only the most extreme levels of comorbidity (e.g. liver disease requires biopsy-proven cirrhosis and renal disease ongoing renal replacement) meaning lesser but perhaps significant comorbidities are not included and cannot be factored into analyses. There are numerous national or large regional ICU databases panning at least four continents. During the COVID-19 pandemic there have been reports from numerous rapidly convened networks. It is likely that no two datasets are the same. This prevents reliable pooling of data that is needed for a better understanding of what is happening across ICUs globally, whether in this pandemic or in other circumstances. The variation in datasets between individual studies based outside databases is wider still. How then can we do better? There is a need for harmonisation of data definition, collection and reporting both in studies and by those organisations collecting population-level data. Achieving this will require significant collaboration and most likely in some cases, humility, to modify long-used definitions and accept new ones. In this context, wider availability of accurate data beyond basic demographic data, to include physiological data, treatments received, and minimal outcomes data is an essential starting point. The ultimate aim is to report large scale data in a timely fashion, using 'real-life' data. For example, in the field of peri-operative medicine, some progress has been made in a similar initiative: two projects working independently to similar goals (the standardised endpoints for peri-operative medicine (StEP) and core outcome measures for peri-operative and anaesthetic care (COMPAC)) have combined as the StEP-COMPAC initiative to standardise definitions for specific outcome measures used in anaesthetic and peri-operative care studies [28] . The COVID-19 admitted to ICU. We also note that outcome from ICU may be impacted by factors other than patient and disease characteristics: these include the type of ICU, interventions undertaken (or withheld), the socio-economic setting of the healthcare service and the extent of systemic stress in that system. In the future, regular reporting in a manner akin to ICNARC's regular reports, using a core outcome set and harmonisation of data definition, collection and reporting on a much broader basisincluding physiological and clinical data acquired in ICUis likely to be not only beneficial, but necessary if we are to better understand this pandemic, the next one and the major health challenges that affect ICUs across the world. Factors associated with mortality in patients with COVID-19 admitted to intensive care: a systematic review and meta-analysis Risk to health from COVID-19 for anaesthetists and intensivists -a narrative review Average age of death (median and mean) of persons whose death was due to COVID-19 or involved COVID-19, by sex, deaths registered up to week ending 2 Features of 20,133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study Intensive Care National audit and Research Centre Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area Outcomes from intensive care in patients with COVID-19: a systematic review and metaanalysis of observational studies Mechanical Ventilation in COVID-19: interpreting the current epidemiology Critical care preparation and management in the COVID-19 pandemic. ICM Anaesthesia COVID-19 hub Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) Dexamethasone in hospitalized Patients with Covid-19 Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Factors associated with COVID-19-related death using OpenSAFELY Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study Critical care for COVID-19 during a humanitarian crisis -lessons learnt from Yemen Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran The African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study The messages deciding between life and death Brazil's health system has 'collapsed' with Covid Trends in intensive care for patients with COVID-19 in England, Wales, and Northern Ireland Benefits and risks of the P/F approach Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom Phenotypes of severe COVID-19 ARDS receiving extracorporeal membrane oxygenation Variability in COVID-19 in-hospital mortality rates between national health service trusts and regions in England: a national observational study for the Getting It Right First Time Programme Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies Intensive Care National Audit and Research Centre. ICNARC report on COVID-19 in critical care: England, Wales and Northern Ireland. 2021 COMPAC-StEP Group. Standardizing end points in perioperative trials: towards a core and extended outcome set No competing interests declared.